NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E–Deficient Mice—Brief Report

van der Heijden, Thomas, Kritikou, Eva, Venema, Wouter, van Duijn, Janine, van Santbrink, Peter J., Slütter, Bram, Foks, Amanda C., Bot, Ilze, Kuiper, Johan·2017·Arteriosclerosis, Thrombosis, and Vascular Biology

DOI 10.1161/atvbaha.117.309575

Cited by (348)

Items 101–200 of 348

NLRP3 inflammasome in cardiovascular diseases: an update
Binhai Mo, Yudi Ding, Qingwei Ji · 2025 · Frontiers in Immunology
Cardiovascular diseases, NLRP3 inflammasome, and western dietary patterns
Luís E. Pavillard, Fabiola Marín‐Aguilar, Pedro Bullón, Mario David Cordero · 2018 · Pharmacological Research
NLRP 3 inflammasome: A likely target for the treatment of allergic diseases
Yichen Xiao, Wenna Xu, Wenru Su · 2018 · Clinical & Experimental Allergy
Protection of MCC950 against Alzheimer's disease via inhibiting neuronal pyroptosis in SAMP8 mice
Jie Li, Lili Zhuang, Xiaoqing Luo, Jianheng Liang, Erwei Sun, Yi He · 2020 · Experimental Brain Research
Clozapine Prevents Poly (I:C) Induced Inflammation by Modulating NLRP3 Pathway in Microglial Cells
Vijayasree Vayalanellore Giridharan, Giselli Scaini, Gabriela Delevati Colpo, Tejaswini Doifode, Omar F. Pinjari, Antônio Lúcio Teixeira, Fabricia Cardoso Petronilho, Danielle S. Macêdo, João Quevedo, Tatiana Barichello · 2020 · Cells
Role of pyroptosis in atherosclerosis and its therapeutic implications
Bin He, Qiangqiang Nie, Feng Wang, Yongxin Han, Bo Yang, Mingsheng Sun, Xueqiang Fan, Zhidong Ye, Peng Liu, Jianyan Wen · 2021 · Journal of Cellular Physiology
Hyperglycemia Aggravates Periodontitis via Autophagy Impairment and ROS-Inflammasome-Mediated Macrophage Pyroptosis
Zhenxing Zhao, Ming Ye, Xiang Li, Hao Tan, Xinyi He, Lan Yang, Jinlin Song, Leilei Zheng · 2023 · International Journal of Molecular Sciences
SIRT3 (Sirtuin-3) Prevents Ang II (Angiotensin II)–Induced Macrophage Metabolic Switch Improving Perivascular Adipose Tissue Function
Tong Wei, Jing Gao, Chenglin Huang, Bei Song, Mengwei Sun, Weili Shen · 2020 · Arteriosclerosis Thrombosis and Vascular Biology
NLRP3 Inflammasome Inhibition by MCC950 in Aged Mice Improves Health via Enhanced Autophagy and PPARα Activity
Fabiola Marín‐Aguilar, Beatriz Castejón‐Vega, Elísabet Alcocer‐Gómez, Débora Lendines‐Cordero, Matthew A. Cooper, Patricia de la Cruz‐Ojeda, Eloísa Andújar, Mónica Pérez-Alegre, Jordi Muntané, Antonio J. Pérez‐Pulido et al. · 2019 · The Journals of Gerontology Series A
Molecular and cellular mechanisms of inflammation in atherosclerosis
Nicoleta‐Monica Popa‐Fotea, Corina Ferdoschi, Miruna-Mihaela Micheu · 2023 · Frontiers in Cardiovascular Medicine
Electrical stimulation inhibits Val-boroPro-induced pyroptosis in THP-1 macrophages via sirtuin3 activation to promote autophagy and inhibit ROS generation
Cong Lin, Ziyu Gao, Yinghong Zheng, Ting Ye, Zitong Wang, Pengyu Wang, Manman Li, Bowen Dong, Wei Ping Yang, Quanfeng Li et al. · 2020 · Aging
Pyroptosis: A promising therapeutic target for noninfectious diseases
Tong Li, Guangjuan Zheng, Ben Li, Lipeng Tang · 2021 · Cell Proliferation
Molecular mechanisms underlying NLRP3 inflammasome activation and IL-1β production in air pollution fine particulate matter (PM2.5)-primed macrophages
Lourdes Cáceres, Tijani Abogunloko, Sara Malchow, Fabienne Ehret, Julian Merz, X. Li, Lucía Sol Mitre, Natalia Magnani, Deborah R. Tasat, Timothy Bon-Nawul Mwinyella et al. · 2023 · Environmental Pollution
MCC950 as a promising candidate for blocking NLRP3 inflammasome activation: A review of preclinical research and future directions
Yujia Zheng, Xiaolu Zhang, Ziyu Wang, Ruifeng Zhang, Huayuan Wei, Yan Xu, Xijuan Jiang, Lin Yang · 2024 · Archiv der Pharmazie
COVID‐19: A Case for Inhibiting NLRP3 Inflammasome, Suppression of Inflammation with Curcumin?
Ali Saeedi‐Boroujeni, Mohammad‐Reza Mahmoudian‐Sani, Mohammad Bahadoram, Arash Alghasi · 2020 · Basic & Clinical Pharmacology & Toxicology
Inflammasomes and Cell Death: Common Pathways in Microparticle Diseases
Maryam Rashidi, Ian P. Wicks, James Edward Vince · 2020 · Trends in Molecular Medicine
Portrayal of NLRP3 Inflammasome in Atherosclerosis: Current Knowledge and Therapeutic Targets
Daniela Maria Tănase, Emilia Valasciuc, Evelina Maria Gosav, Anca Ouatu, Oana Nicoleta Buliga-Finiș, Mariana Floria, Minela Aida Maranducă, Ionela Lăcrămioara Șerban · 2023 · International Journal of Molecular Sciences
Gasdermin D Mediates Inflammation-Induced Defects in Reverse Cholesterol Transport and Promotes Atherosclerosis
Emmanuel Opoku, C. Alicia Traughber, David K. Y. Zhang, Amanda J. Iacano, Mariam R. Khan, Juying Han, Jonathan D. Smith, Kailash Gulshan · 2021 · Frontiers in Cell and Developmental Biology
New possible pharmacological targets for statins and ezetimibe
Mateusz Niedzielski, Marlena Broncel, Paulina Gorzelak‐Pabiś, Ewelina Woźniak · 2020 · Biomedicine & Pharmacotherapy
Therapeutic potential of sulfur-containing natural products in inflammatory diseases
Xu Cao, Lei Cao, Wencan Zhang, Rongzhu Lu, Jin‐Song Bian, Xiaowei Nie · 2020 · Pharmacology & Therapeutics
Innate immune cells in the pathophysiology of calcific aortic valve disease: lessons to be learned from atherosclerotic cardiovascular disease?
Wieteke Broeders, Siroon Bekkering, Saloua El Messaoudi, Leo A. B. Joosten, Niels van Royen, Niels Peter Riksen · 2022 · Basic Research in Cardiology
Luteolin inhibits NLRP3 inflammasome activation via blocking ASC oligomerization
Mi Nam Lee, Youngyoon Lee, Dayong Wu, Munkyong Pae · 2021 · The Journal of Nutritional Biochemistry
Interactions between NLRP3 inflammasome and glycolysis in macrophages: New insights into chronic inflammation pathogenesis
Qun Yu, Maojuan Guo, Wenyun Zeng, Miao Zeng, Xiaolu Zhang, Yue Zhang, Wenlan Zhang, Xijuan Jiang, Bin Yu · 2021 · Immunity Inflammation and Disease
Lipid-laden foam cells in the pathology of atherosclerosis: shedding light on new therapeutic targets
Cristi Lara Galindo, Saifur Rahman Khan, Xiangyu Zhang, Yu‐Sheng Yeh, Ziyang Liu, Babak Razani · 2023 · Expert Opinion on Therapeutic Targets
Baicalin Inhibits NLRP3 Inflammasome Activity Via the AMPK Signaling Pathway to Alleviate Cerebral Ischemia-Reperfusion Injury
Wenxia Zheng, Wenqi He, Qianrui Zhang, Jin-Xin Jia, Sheng Zhao, Fang-jian Wu, Xiaolu Cao · 2021 · Inflammation
Modern Concepts in Cardiovascular Disease: Inflamm-Aging
Yustina M. Puspitasari, Stefano Ministrini, Lena Schwarz, Caroline Karch, Luca Liberale, Giovanni Guido Camici · 2022 · Frontiers in Cell and Developmental Biology
Chronic inflammation and vascular cell plasticity in atherosclerosis
Alexander Lin, Joseph M. Miano, Edward A A Fisher, Ashish Misra · 2024 · Nature Cardiovascular Research
Macrophages and T cells in atherosclerosis: a translational perspective
Benjamin Bartlett, Herbert P. Ludewick, Ashish Misra, Silvia Lee, Girish Dwivedi · 2019 · American Journal of Physiology-Heart and Circulatory Physiology
Crystalline silica particles cause rapid NLRP3-dependent mitochondrial depolarization and DNA damage in airway epithelial cells
Rongrong Wu, Johan Högberg, Mikael Adner, Patricia Ramos‐Ramírez, Ulla Stenius, Huiyuan Zheng · 2020 · Particle and Fibre Toxicology
NLRP3-Mediated Inflammation in Atherosclerosis and Associated Therapeutics
Na Lu, Weijia Cheng, Dongling Liu, Gang Liu, Can Cui, Chaoli Feng, Xianwei Wang · 2022 · Frontiers in Cell and Developmental Biology
The role of NLRP3 inflammasome in sepsis: A potential therapeutic target
Wenfang He, Haiyun Dong, Chenfang Wu, Yanjun Zhong, Jinxiu Li · 2023 · International Immunopharmacology
Caspase-1-dependent inflammasomes mediate photoreceptor cell death in photo-oxidative damage-induced retinal degeneration
Yvette Wooff, Nilisha Fernando, Josephine H. C. Wong, Catherine A. Dietrich, Riemke Aggio‐Bruce, Joshua A. Chu‐Tan, Avril A. B. Robertson, Sarah Doyle, Si Ming Man, Riccardo Natoli · 2020 · Scientific Reports
Spotlight on NLRP3 Inflammasome: Role in Pathogenesis and Therapies of Atherosclerosis
Chunteng Jiang, Santuan Xie, Guang Yang, Ningning Wang · 2021 · Journal of Inflammation Research
Hypermethylation of the Micro-RNA 145 Promoter Is the Key Regulator for NLRP3 Inflammasome-Induced Activation and Plaque Formation
Wei Hong Zhong, Bo Li, Yao Xu, Ping Yang, Rui Chen, Zhongqun Wang, Chen Shao, Juan Song, Jinchuan Yan · 2018 · JACC Basic to Translational Science
NLRP3 Inflammasome: A Potential Alternative Therapy Target for Atherosclerosis
Yang Liu, Chao Li, Honglin Yin, Xinrong Zhang, Yunlun Li · 2020 · Evidence-based Complementary and Alternative Medicine
The IL-1 Family and Its Role in Atherosclerosis
Leticia González, Katherine Rivera, Marcelo E. Andía, Gonzalo Martı́nez-Rodrı́guez · 2022 · International Journal of Molecular Sciences
Viral proteases activate the CARD8 inflammasome in the human cardiovascular system
Rhea Nadkarni, Werncui Chu, Cheryl Q. E. Lee, Yasir Mohamud, Lynn Yap, Gee Ann Toh, Sheryl Beh, Radiance Lim, Yiyun Michelle Fan, Yizhuo Lyanne Zhang et al. · 2022 · The Journal of Experimental Medicine
NLRP3 inflammasome inactivation driven by miR‑223‑3p reduces tumor growth and increases anticancer immunity in breast cancer
Liping Zhang, Hongzhi Li, Yuwei Zang, Feng Wang · 2019 · Molecular Medicine Reports
Inhibition of the NLRP3 inflammasome attenuates foam cell formation of THP-1 macrophages by suppressing ox-LDL uptake and promoting cholesterol efflux
Liang Chen, Qiying Yao, Siwei Xu, Hongyan Wang, Peng Qu · 2017 · Biochemical and Biophysical Research Communications
Intersection of immunometabolism and immunosenescence during aging
Kyoo-a Lee, Paul D. Robbins, Christina D. Camell · 2021 · Current Opinion in Pharmacology
Tranilast: a potential anti-Inflammatory and NLRP3 inflammasome inhibitor drug for COVID-19
Ali Saeedi‐Boroujeni, Mohammad‐Reza Mahmoudian‐Sani, Roohangiz Nashibi, Sheyda Houshmandfar, Sima Tahmaseby Gandomkari, Ali Khodadadi · 2021 · Immunopharmacology and Immunotoxicology
Non-canonical NF-κB contributes to endothelial pyroptosis and atherogenesis dependent on IRF-1
Xing Fan, Jingyu Li, Yiying Wang, Dai‐Min Zhang, Jingchao Zhou, Qing Chen, Liang Sheng, Anthony G. Passerini, Chongxiu Sun · 2022 · Translational research
Emerging Roles of Inflammasomes in Cardiovascular Diseases
Yingnan Liao, Kui Liu, Liyuan Zhu · 2022 · Frontiers in Immunology
NLRP3 inflammasome activation, metabolic danger signals, and protein binding partners
Sy‐Ying Leu, Yi-Ling Tsang, Li‐Chun Ho, Ching-Chun Yang, Ai‐Ning Shao, Chia-Yu Chang, Hui-kuan Lin, Pei-Jane Tsai, Junne‐Ming Sung, Yau-Sheng Tsai · 2023 · Journal of Endocrinology
SGLT-2 Inhibitors and the Inflammasome: What’s Next in the 21st Century?
Dimitris C. Kounatidis, Natalia G. Vallianou, Angelos A Evangelopoulos, Ioannis Vlahodimitris, Eugenia Grivakou, Evangelia Kotsi, Krystalia Dimitriou, Alexandros Skourtis, Iordanis S. Mourouzis · 2023 · Nutrients
Inflammasomes: a novel therapeutic target in pulmonary hypertension?
Tara Scott, Barbara K. Kemp‐Harper, Adrian J. Hobbs · 2018 · British Journal of Pharmacology
Gasdermin D Deficiency Limits the Transition of Atherosclerotic Plaques to an Inflammatory Phenotype in ApoE Knock-Out Mice
Pauline Puylaert, Melissa Van Praet, Frederik Vaes, Cedric H. G. Neutel, Lynn Roth, Pieter‐Jan Guns, Guido R.Y. De Meyer, Wim Martinet · 2022 · Biomedicines
Anti‐inflammatory therapy for atherosclerosis: interpreting divergent results from the CANTOS and CIRT clinical trials
Paul M. Ridker · 2018 · Journal of Internal Medicine
Effect of Biologics on Cardiovascular Inflammation: Mechanistic Insights and Risk Reduction
G. Fragoulis, Στέργιος Σουλαϊδόπουλος, Petros Paul Sfikakis, Theodoros Dimitroulas, George D. Kitas · 2021 · Journal of Inflammation Research
Cholesterol crystals in the pathogenesis of atherosclerosis
Yvonne Baumer, Jason S. Irei, William A. Boisvert · 2024 · Nature Reviews Cardiology
The Role of the Interplay Between Autophagy and NLRP3 Inflammasome in Metabolic Disorders
Shuangyu Lv, Honggang Wang, Xiaotian Li · 2021 · Frontiers in Cell and Developmental Biology
Therapeutic interventions target the NLRP3 inflammasome in ulcerative colitis: Comprehensive study
Fares E.M. Ali, Islam Mohamed Ibrahim, Osama M Ghogar, Esraa K. Abd‐alhameed, Hanan S. Althagafy, Emad H. M. Hassanein · 2023 · World Journal of Gastroenterology
Britannin as a novel NLRP3 inhibitor, suppresses inflammasome activation in macrophages and alleviates NLRP3-related diseases in mice
Jing-jing Shao, Weifeng Li, Jinfeng Sun, Zaishou Zhuang, Julian Min, Xiaohong Long, Gaojun Wu, Haowen Xu, Guang Liang · 2024 · Acta Pharmacologica Sinica
Activation of the ROS/TXNIP/NLRP3 pathway disrupts insulin-dependent glucose uptake in skeletal muscle of insulin-resistant obese mice
Javier Russell‐Guzmán, Luan Américo-Da-Silva, Cynthia Cadagan, Martín Maturana, Jesús Palomero, Manuel Estrada, Genaro C. Barrientos, Sonja Buvinic, Cecilia Hidalgo, Paola Llanos · 2024 · Free Radical Biology and Medicine
Inflammasome-Driven Interleukin-1α and Interleukin-1β Production in Atherosclerotic Plaques Relates to Hyperlipidemia and Plaque Complexity
Xintong Jiang, Feilong Wang, Yajuan Wang, Anton Gisterå, Joy Roy, Gabrielle Paulsson‐Berne, Ulf Hedin, Amir Lerman, Göran K. Hansson, Joerg Herrmann et al. · 2019 · JACC Basic to Translational Science
Pyroptosis in NLRP3 inflammasome-related atherosclerosis
Xiang Zeng, Dongling Liu, Xia Huo, Yue Wu, Cuiqing Liu, Qinghua Sun · 2022 · Cell Stress
P2X Antagonists Inhibit HIV-1 Productive Infection and Inflammatory Cytokines Interleukin-10 (IL-10) and IL-1β in a Human Tonsil Explant Model
Alexandra Y. Soare, Natasha D. Durham, Ramya Gopal, Benjamin C. Tweel, Kevin W. Hoffman, Julia A. Brown, Megan O’Brien, Nina Bhardwaj, Jean K. Lim, Benjamin K. Chen et al. · 2018 · Journal of Virology
NLRP3 Inflammasome Signaling as a Link Between HIV-1 Infection and Atherosclerotic Cardiovascular Disease
Caroline E. Mullis, Talia H. Swartz · 2020 · Frontiers in Cardiovascular Medicine
The Potential of NLRP3 Inflammasome as a Therapeutic Target in Neurological Diseases
Wenfang He, Zhiping Hu, Yanjun Zhong, Chenfang Wu, Jinxiu Li · 2023 · Molecular Neurobiology
Recent Advances in Anti‐Atherosclerosis and Potential Therapeutic Targets for Nanomaterial‐Derived Drug Formulations
Zhicheng Xiao, Yi Li, Liyan Xiong, Jun Liao, Yijun Gao, Yunchun Luo, Yun Wang, Ting Chen, Dahai Yu, Tingfang Wang et al. · 2023 · Advanced Science
The NLRP3 Inflammasome and Its Role in the Pathogenicity of Leukemia
Laura Urwanisch, Michela Luciano, Jutta Horejs‐Hoeck · 2021 · International Journal of Molecular Sciences
Targeting the NLRP3 Inflammasome via BTK
Alexander N.R. Weber · 2021 · Frontiers in Cell and Developmental Biology
Effects of IL-38 on Macrophages and Myocardial Ischemic Injury
Zhiyang Li, Yan Ding, Yudong Peng, Jian Yu, Chengliang Pan, Yifan Cai, Qian Dong, Yucheng Zhong, Ruirui Zhu, Kunwu Yu et al. · 2022 · Frontiers in Immunology
The NLRP3 inflammasome: Multiple activation pathways and its role in primary cells during ventricular remodeling
Zhipeng Yan, Zhongwen Qi, Xiaoya Yang, Nan Ji, Yueyao Wang, Qi Wu Shi, Meng Li, Junping Zhang, Yaping Zhu · 2021 · Journal of Cellular Physiology
NLRP3-mediated inflammation in cardio-oncology: sterile yet harmful
Adolfo Gabriele Mauro, Eleonora Mezzaroma, Stefano A Toldo, Giselle C. Meléndez, R. Lee Franco, Edward Joseph Lesnefsky, Antonio Abbate, William Gregory Hundley, Fadi N. Salloum · 2022 · Translational research
The emerging role of pyroptosis-related inflammasome pathway in atherosclerosis
Xiaodan Xu, Jiaxian Chen, Lin Zhu, Shuting Xu, Jian Jiang, Kun Ren · 2022 · Molecular Medicine
NLRP3 Inflammasome as a Common Denominator of Atherosclerosis and Abdominal Aortic Aneurysm
Masafumi Takahashi · 2021 · Circulation Journal
Inflammaging, an Imbalanced Immune Response That Needs to Be Restored for Cancer Prevention and Treatment in the Elderly
Juana Serrano‐López, Beatriz Martín-Antonio · 2021 · Cells
Interleukin-1 in Coronary Artery Disease
Evangelos K. Oikonomou, Paraskevas Tsaplaris, Artemis Anastasiou, Maria Xenou, Stamatios Lampsas, Gerasimos Siasos, Panteleimon Pantelidis, Panagiotis Theofilis, Aikaterini Tsatsaragkou, Ουρανία Κατσαρού et al. · 2022 · Current Topics in Medicinal Chemistry
The selective NLRP3 inflammasome inhibitor MCC950 improves isoproterenol-induced cardiac dysfunction by inhibiting cardiomyocyte senescence
Ying Shi, Lili Zhao, Jing Wang, Shan Liu, Yifei Zhang, Qin Qin · 2022 · European Journal of Pharmacology
S100a8/A9 proteins: critical regulators of inflammation in cardiovascular diseases
Yu Sun, Xu Han, Weihan Gao, Jinlan Deng, Xiayinan Song, Jie Li, Xijian Liu · 2024 · Frontiers in Cardiovascular Medicine
Immune-based therapies in cardiovascular and metabolic diseases: past, present and future
Andrew James Murphy, Mark Anthony Febbraio · 2021 · Nature reviews. Immunology
The Elusive Origin of Atherosclerotic Plaque Calcification
Emmanuelle Canet‐Soulas, Laurence Bessueille, Laura Mechtouff, David Magne · 2021 · Frontiers in Cell and Developmental Biology
Natural Monoterpenes as Potential Therapeutic Agents against Atherosclerosis
Jing Yang, Chao Zhong, Jun Yu · 2023 · International Journal of Molecular Sciences
Interactions between PCSK9 and NLRP3 inflammasome signaling in atherosclerosis
Yanan Wang, Dan Fang, Qinzhi Yang, Jingcan You, Liqun Wang, Jianbo Wu, Min Zeng, Mao Luo · 2023 · Frontiers in Immunology
RORγ regulates the NLRP3 inflammasome
Cyrielle Billon, Meghan H. Murray, Amer Avdagic, Thomas P. Burris · 2018 · Journal of Biological Chemistry
Pharmacology of Pulmonary Arterial Hypertension: An Overview of Current and Emerging Therapies
Monika Spaczyńska-Kwiatkowska, Susana F. Rocha, Eduardo Oliver · 2020 · ACS Pharmacology & Translational Science
Inflammation in Coronary Atherosclerosis and Its Therapeutic Implications
Nicholas Joseph Montarello, Mau T. Nguyen, Dennis T. L. Wong, Stephen James Nicholls, Peter James Psaltis · 2020 · Cardiovascular Drugs and Therapy
The NLRP3 Inflammasome as a Pathogenic Player Showing Therapeutic Potential in Rheumatoid Arthritis and Its Comorbidities: A Narrative Review
Po‐Ku Chen, Kuo‐Tung Tang, Der‐Yuan Chen · 2024 · International Journal of Molecular Sciences
NLRP3 inhibition improves heart function in GPER knockout mice
Hao Wang, Xuming Sun, Hunter S. Hodge, Carlos Maria Ferrario, Leanne Groban · 2019 · Biochemical and Biophysical Research Communications
Role of Pyroptosis and Ferroptosis in the Progression of Atherosclerotic Plaques
Zhen Yang, Junhe Shi, Li Chen, Changgeng Fu, Dazhuo Shi, Hua Qu · 2022 · Frontiers in Cell and Developmental Biology
Immunological perspectives on atherosclerotic plaque formation and progression
Hui Pi, Guangliang Wang, Yu Wang, Ming Zhang, Qin He, Xi‐Long Zheng, Kai Yin, Guojun Zhao, Ting Jiang · 2024 · Frontiers in Immunology
Inflammasome Activation-Induced Hypercoagulopathy: Impact on Cardiovascular Dysfunction Triggered in COVID-19 Patients
Lealem Gedefaw, Sami Ullah, Polly H. M. Leung, Yin Cai, Shea Ping Yip, Chien‐Ling Huang · 2021 · Cells
Novel Anti-Inflammatory Therapies in Coronary Artery Disease and Acute Coronary Syndromes
Yannis Dimitroglou, Constantina Aggeli, Panagiotis Theofilis, Panagiotis Tsioufis, Evangelos K. Oikonomou, Christos Chasikidis, Konstantinos P Tsioufis, Dimitris Tousoulis · 2023 · Life
Molecular Activation of NLRP3 Inflammasome by Particles and Crystals: A Continuing Challenge of Immunology and Toxicology
Qiang Ma, Chol Seung Lim · 2023 · The Annual Review of Pharmacology and Toxicology
miR-223-3p Prevents Necroptotic Macrophage Death by Targeting Ripk3 in a Negative Feedback Loop and Consequently Ameliorates Advanced Atherosclerosis
Yunhui Jia, Lianping Cheng, Jiaxuan Yang, Jia-Qi Mao, Yuhuai Xie, Xian‐Wen Yang, Xin Zhang, Dingxin Wang, Zhen Zhao, Andreas Schober et al. · 2023 · Arteriosclerosis Thrombosis and Vascular Biology
Role of inflammation and evidence for the use of colchicine in patients with acute coronary syndrome
Juan Francisco Bulnes, Leticia González, Leonardo Velásquez, Orellana María Paz, Paula Muñoz Venturelli, Gonzalo Martínez · 2024 · Frontiers in Cardiovascular Medicine
Chemical Modulation of Gasdermin-Mediated Pyroptosis and Therapeutic Potential
Christopher B. Ryder, Hannah C. Kondolf, Meghan E O'Keefe, Bowen Zhou, Derek W. Abbott · 2021 · Journal of Molecular Biology
Antiatherosclerotic effect of dehydrocorydaline on ApoE−/− mice: inhibition of macrophage inflammation
Bin Wen, Yuanye Dang, Suhua Wu, Yi-min Huang, Kongyang Ma, Yiming Xu, Xi‐Long Zheng, Xiao-yan Dai · 2021 · Acta Pharmacologica Sinica
Selective NLRP3 Inflammasome Inhibitor MCC950 Suppresses Inflammation and Facilitates Healing in Vascular Materials
Angus J. Grant, Nianji Yang, Matthew Moore, Yuen Ting Lam, Praveesuda L. Michael, Alex Chan, Miguel Santos, Jelena Rnjak‐Kovacina, Richard P. Tan, Steven G. Wise · 2023 · Advanced Science
Inhibiting NLRP3 Inflammasome Activity in Acute Myocardial Infarction: A Review of Pharmacologic Agents and Clinical Outcomes
Leo Francis Buckley, Peter Libby · 2019 · Journal of Cardiovascular Pharmacology
Elucidating emerging signaling pathways driving endothelial dysfunction in cardiovascular aging
Anna De Bartolo, Tommaso Angelone, Carmine Rocca · 2025 · Vascular Pharmacology
Mechanisms and therapeutic potential of pharmacological agents targeting inflammasomes
Haitao Li, Tiantian Liu, Xuezhen Shi, Hao Du, Chengzhi Cai, Duomeng Yang, Lili Qu, Huixin Dou, Boyan Jiao, Baihai Jiao · 2025 · Biomedicine & Pharmacotherapy
Inhibiting the inflammasome with MCC950 counteracts muscle pyroptosis and improves Duchenne muscular dystrophy
Nicolas Dubuisson, María A. Davis‐López de Carrizosa, Romain Versele, Camille M. Selvais, Laurence Noël, P. Y. D. Van den Bergh, Sonia M. Brichard, Michel Abou‐Samra · 2022 · Frontiers in Immunology
Sterol-resistant SCAP Overexpression in Vascular Smooth Muscle Cells Accelerates Atherosclerosis by Increasing Local Vascular Inflammation through Activation of the NLRP3 Inflammasome in Mice
Li, Danyang, Liu, Mihua, Li, Zhe, Zheng, Guo, Chen, Amei, Zhao, Lei, Yang, Ping, Wei, Li, Chen, Yaxi, Ruan, Xiong Z. · 2021 · Aging and disease
Inflammation and Heart Failure: Searching for the Enemy—Reaching the Entelechy
IOANNIS A. PARASKEVAIDIS, Dimitrios T. Farmakis, Georgios Papingiotis, Elias Tsougos · 2023 · Journal of Cardiovascular Development and Disease
NLRP3 Inflammasome: A Novel Player in Metabolically Induced Inflammation—Potential Influence on the Myocardium
Marina Sokolova, Trine Ranheim, Mieke C. Louwe, Bente Lise Halvorsen, Arne Yndestad, Pål Aukrust · 2019 · Journal of Cardiovascular Pharmacology
Innate Immune Pathways in Atherosclerosis—From Signaling to Long-Term Epigenetic Reprogramming
Arailym Aronova, Federica Tosato, Nawraa Naser, Yaw Asare · 2023 · Cells
Recent Advances in Targeted Management of Inflammation In Atherosclerosis: A Narrative Review
Rafael Zubirán, Edward B. Neufeld, Amaury Dasseux, Alan Thomas Remaley, Alexander V. Sorokin · 2024 · Cardiology and Therapy
Damage-associated molecular patterns (DAMPs) in vascular diseases
Jacob Antonello, Partha Sarathi Roy · 2025 · Journal of Biological Chemistry